- Home
- SCLX
as 11-17-2025 3:26pm EST
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | PALO ALTO |
| Market Cap: | 139.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 140.1K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -45.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.60 - $34.27 | Next Earning Date: | 08-13-2025 |
| Revenue: | $40,360,000 | Revenue Growth: | -12.98% |
| Revenue Growth (this year): | 89.26% | Revenue Growth (next year): | 203.95% |
Latest Scilex Holding Company News
SCLX Breaking Stock News: Dive into SCLX Ticker-Specific Updates for Smart Investing
PR Newswire
13 hours ago
Oramed Reports Fiscal Third Quarter 2025 Financial Results
GlobeNewswire
14 hours ago
Datavault AI Reports 3Q-25 Highlights and Corporate Update
MarketBeat
7 days ago
Datavault AI's 314% Upside: Huge Potential or Wall Street Mirage?
GlobeNewswire
13 days ago
Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information
GlobeNewswire
14 days ago
Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AI
Simply Wall St.
20 days ago
Scilex Holding Company (NASDAQ:SCLX) Is Expected To Breakeven In The Near Future
MT Newswires
a month ago
Datavault AI Converts $13.3 Million in Convertible Debt
GlobeNewswire
2 months ago
Datavault AI Converts $13.3 Million in Convertible Debt, Strengthens Balance Sheet
Compare SCLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SCLX Scilex Holding Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.